SNX9 Antikörper (AA 85-200)

Produktnummer ABIN7170408

Produktdetails anti-SNX9 Antikörper

Target: SNX9 (Sorting Nexin 9 (SNX9))

Bindungsspezifität: AA 85-200

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SNX9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Sorting nexin-9 protein (85-200AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu SNX9

Target: SNX9 (Sorting Nexin 9 (SNX9))

Andere Bezeichnung: SNX9 (SNX9 Produkte)

Synonyme: si:bz36d5.4 antikoerper, snx9 antikoerper, zgc:113455 antikoerper, MGC78823 antikoerper, SNX9 antikoerper, SDP1 antikoerper, SH3PX1 antikoerper, SH3PXD3A antikoerper, WISP antikoerper, 2700073N08Rik antikoerper, sorting nexin 9a antikoerper, sorting nexin 9 antikoerper, sorting nexin 9 L homeolog antikoerper, snx9a antikoerper, SNX9 antikoerper, snx9.L antikoerper, snx9 antikoerper, Snx9 antikoerper

Hintergrund:

Background: Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Promotes internalization of TNFR. Promotes degradation of EGFR after EGF signaling. Stimulates the GTPase activity of DNM1. Promotes DNM1 oligomerization. Promotes activation of the Arp2/3 complex by WASL, and thereby plays a role in the reorganization of the F-actin cytoskeleton. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Has lower affinity for membranes enriched in phosphatidylinositol 3-phosphate.

Aliases: MST 155 antibody, MST155 antibody, MSTP 155 antibody, MSTP155 antibody, OTTHUMP00000040083 antibody, Protein SDP 1 antibody, Protein SDP1 antibody, SDP 1 antibody, SDP1 antibody, SH3 and PX domain containing protein 3A antibody, SH3 and PX domain containing protein SH3PX1 antibody, SH3 and PX domain-containing protein 1 antibody, SH3 and PX domain-containing protein 3A antibody, SH3PX1 antibody, SH3PXD3A antibody, SNX 9 antibody, SNX9 antibody, SNX9_HUMAN antibody, Sorting nexin 9 antibody, Sorting nexin-9 antibody, WASP interactor protein antibody, Wiskott Aldrich syndrome protein (WASP) interactor protein antibody, Wiskott Aldrich syndrome protein interactor protein antibody, WISP antibody

UniProt: Q9Y5X1